Optimizing Antiplatelet Therapy in Cardiogenic Shock-Concluding Remarks, Dr. Sandeep Nathan

Concluding Remarks, Dr. Sandeep Nathan

Video Transcription

Video Summary

In this brief closing session, participants were asked about their anticipated use of Kangalore after the discussion. Responses varied between no change, increases, or having just started using it. Some reported acquiring Kangalore at their facilities. When asked about clinical scenarios for Kangalore use, most favored acute coronary syndrome (ACS). The session concluded with thanks to the presenters, including Dr. Jen Reimer, panelists, and attendees for their participation and attention.

Keywords

Kangalore usage

acute coronary syndrome

clinical scenarios

participant feedback

closing session